The Start-up Meeting of Tyroserleutide Phase III Clinical Trial in the Xiangya Hospital Central-South University

Date:
2011-12-05
Category:
Company News

The start-up meeting of Tyroserleutide Phase III clinical trial in the Xiangya Hospital Central-South University was successfully held in the conference room of hepatobiliary surgery department on 21 November 2011, and relevant experts of Xiangya Hospital Central-South University and the institution of clinical trial were invited to present the meeting. Meanwhile, Medpace Company (the Clinical Research Organization of this clinical trial) also attended the conference. Our Marketing Managers and medical department introduced the research process of Tyroserleutide as well as the background and the prospect of the Tyroserleutide Phase III clinical trial, and also gave a detailed introduction of the protocol, operation procedure and standardized procedure of Tyroserleutide Phase III clinical trial, and also discussed and exchanged some common consideration regarding to this clinical trial. The success of this meeting laid a solid foundation for the Phase III clinical research of Tyroserleutide.